Clinical Trial: Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146217) titled 'Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection' on Aug. 08.

Brief Summary: This is an open-label, single-arm, pharmacokinetic and safety study of Likmez(R) in pediatric patients aged 12 months to <4 years with anaerobic bacterial infection

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Bacterial Infections

Intervention: DRUG: Likmez(R) (metronidazole) Oral Suspension

Each patient will receive 7.5 mg/kg of Likmez(R) every 6 hours, with a concentration of 100 mg metronidazole/mL

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sapta...